RE:RE:Bioassets, EPS and market cap come Q3 2019Agreed Walter. Come Q3/Q4, these guys will begin to stand out against other small caps. Their revenues will continue to rise for the foreseeable future and as long as they can continue to manage their cash efficiently, I can't see us sitting at these levels by year end. The summer lull coupled with no news until End-July has resulted in a lack of volume and traders investing elsewhere.
]
Walterthedog wrote: I agree there is a ticking time bomb there as investors will catch wind of a major increase like that quickly. Thats why i was surprised we didn't rise more with the news about getting the license. However if you think that they will get their upper end estimates of 27 000 kgs and then be able to sell it for 6$/gram or even the eventual equivalent in oil sales you must be pretty high. Even if you can get a little better margins on oil, theres no way they will post such an increase based on an outdoor crop that would face an increased amount of uncertainty. You also have to take out costs to produce. I'm guessing they post an increase of 30 to 50M$. Thats still awesome when tacked on to your eps for the quarter and i fully believe it'll get more eyes on WMD.